Rapid SARS-CoV-2 Seroprevalence Survey in Central and Western Divisions of Fiji, 2021 - Volume 29, Number 1—January 2023 - Emerging Infectious Diseases journal - CDC
This research output has an Altmetric Attention Score of 4. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 01 January 2023.
All research outputs
#11,070,130
of 33,738,238 outputs
Outputs from Emerging Infectious Diseases
#6,771
of 10,980 outputs
Outputs of similar age
#164,704
of 526,500 outputs
Outputs of similar age from Emerging Infectious Diseases
#88
of 138 outputs
Altmetric has tracked 33,738,238 research outputs across all sources so far. This one has received more attention than most of these and is in the 66th percentile.
So far Altmetric has tracked 10,980 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 46.7. This one is in the 36th percentile – i.e., 36% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 526,500 tracked outputs that were published within six weeks on either side of this one in any source. This one has gotten more attention than average, scoring higher than 67% of its contemporaries.
We're also able to compare this research output to 138 others from the same source and published within six weeks on either side of this one. This one is in the 34th percentile – i.e., 34% of its contemporaries scored the same or lower than it.
